ROLE: Associate Creative Director, Copywriting
REVLIMID is an oral therapy indicated for the treatment of multiple myeloma—an incurable cancer of the plasma cells in the blood. It's also indicated for several other blood cancers.
I wrote the REVLIMID patient website for multiple myeloma. To see the full site visit https://www.revlimid.com